ACLS MEDICATIONS
Several key medications play vital roles in ACLS algorithms for managing cardiac arrest and other life-threatening conditions. These medications are typically administered intravenously (IV) or intraosseously (IO) by trained healthcare professionals.
KEY ACLS MEDICATIONS
Epinephrine: Epinephrine is a potent vasopressor and cardiac stimulant. It is the primary medication used in cardiac arrest for all rhythms (pulseless VT, VF, asystole, and PEA). Epinephrine works by increasing heart rate, strengthening cardiac contractions, and constricting blood vessels, which helps improve blood flow to the heart and brain.
Amiodarone: Amiodarone is an antiarrhythmic medication used to treat certain ventricular arrhythmias, specifically ventricular fibrillation (VF) and pulseless ventricular tachycardia (VT) that are unresponsive to defibrillation.
Lidocaine: Lidocaine is another antiarrhythmic medication that can be considered as an alternative to amiodarone in certain cases of VF/pulseless VT.
Atropine: Atropine is an anticholinergic medication used to treat symptomatic bradycardia (slow heart rate) when it is causing significant symptoms such as hypotension or poor perfusion. However, its use in bradycardia algorithms has been de-emphasized in recent guidelines.
OTHER MEDICATIONS
Other medications may be used in specific ACLS situations, such as:
ROUTES OF ADMINISTRATION
The preferred route of medication administration in ACLS is intravenous (IV). If IV access is not readily available, the intraosseous (IO) route can be used as an alternative. The IO route involves inserting a needle into the bone marrow, which provides access to the vascular system.
IMPORTANT CONSIDERATIONS